 |
|
|
| |
Key Drivers and Barriers to Treatment Initiation and Adherence in Individuals with Hepatitis C
|
| |
| |
Reported by Jules Levin
DDW May 18-21 2013 Orlando Florida
Suchin Virabhak1, Kathleen Beusterien2, Suzanne Lane3, Stephanie Kirbach4, Shelagh Szabo3, Eric Kallwitz5, Jessica Grinspan2, Katherine Gooch4
1AbbVie Private Limited, Singapore, 2Oxford Outcomes Ltd, Bethesda, MD, United States 3Oxford Outcomes Ltd, Vancouver, BC, Canada 4AbbVie Inc., North Chicago, IL, United States, 5Loyola University Medical Center, Maywood IL, United States.
|
| |
|
|
|
|
|
